$200M Venture Capital For Emerging Public Health Risks
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on February 16, 2006
Kleiner Perkins Caufield & Byers is a reputable venture capital firm in Silicon Valley which has provided financial backing to some of the best known technology and biotech firms today, including Google Inc., Genentech, Inc, Sun Microsystems, Inc, and Amazon.com Inc..
This time, Kleiner aims its venture capital at emerging public health risks. The firm said yesterday that it had raised a total of $200 million for the KPCB Pandemic and Bio Defense Fund, which will be invested in companies working on fighting emerging biological threats, including the bird flu pandemic.
Kleiner also raised $600 million for its 12th general venture fund, $100 million of which will be invested in clean energy technologies.
Read more from Washington Post.
Tags: venture healthcare biotech capital health venture+capital public+health emerging+public
Vote for $200M Venture Capital For Emerging Public Health Risks:
|
Rating: 8.00 out of 1 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells